No Data
No Data
Piper Sandler Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Cuts Target Price to $2
Insider Sale: See Remarks of $PACB Sells 100,773 Shares
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
Where Pacific Biosciences Stands With Analysts
Express News | Goldman Sachs Maintains Neutral on Pacific Biosciences, Lowers Price Target to $1.5
Morgan Stanley Maintains Pacific Biosciences of California(PACB.US) With Hold Rating, Maintains Target Price $2
Day Lily : Hello, how do you get in at such a low price? When was this at 0.0541?
TheFather OP Day Lily : I sell shares the same percentage they sell. SureBet & LongTermSpecial
TheFather OP : Have a profitable week, my friends!
TheFather OP : Up this morning, I took some more profits.
TheFather OP : Here you go, join us!
TheFather :TheFather's Moomooers Lounge is here!
https://www.moomoo.com/community/feed/114060252479493?share_code=02B2ok
View more comments...